https://www.cancertherapyadvisor.com/home/news/conference-coverage/suo-2023/genomic-clinicopathologic-risk-groups-prognostication-prostate-cancer/
0
0
12/3/23 at 4:00pm
Organization
Cancertherapyadvisor.com
Author
Julie Ehlers
34 words
0
Comments
Researchers have found that genomic risk distribution can vary widely across clinical stage groups among patients with prostate cancer.
You are the first to view
Create an account
or login to join the discussion